XAMPENSO

Serial Number 97528305
Registration 7156951
700

Registration Progress

Application Filed
Aug 1, 2022
Under Examination
Approved for Publication
Jun 20, 2023
Published for Opposition
Jun 20, 2023
Registered
Sep 5, 2023

Trademark Image

XAMPENSO

Basic Information

Serial Number
97528305
Registration Number
7156951
Filing Date
August 1, 2022
Registration Date
September 5, 2023
Published for Opposition
June 20, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 5, 2023
Registration
Registered
Classes
005

Rights Holder

Fresenius Kabi Deutschland GmbH

16
Address
Else-Kroener-Str. 1
Bad Homburg 61352
DE

Ownership History

Fresenius Kabi Deutschland GmbH

Original Applicant
16
Bad Homburg DE

Fresenius Kabi Deutschland GmbH

Owner at Publication
16
Bad Homburg DE

Fresenius Kabi Deutschland GmbH

Original Registrant
16
Bad Homburg DE

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
1348 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230905)
Due Date
September 05, 2029
Grace Period Ends
March 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Sep 5, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 5, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 20, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 20, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 31, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 17, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 17, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 22, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 4, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; pharmaceutical preparations for the treatment of CAR T-cell induced cytokine release syndrome

Classification

International Classes
005